# SaeboGlove Therapy for Severe Upper Limb Disability and Severe Hand Impairment After Stroke

Study · id `cardio:ct-nct04007315` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04007315](<https://clinicaltrials.gov/study/NCT04007315>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04007315

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 110 participants.

## Technical summary

Registry record NCT04007315. Randomized; single masking; primary purpose treatment. Start 2019-11-21 (actual); primary completion 2022-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 110 participants (planned count; ClinicalTrials.gov record NCT04007315, source copy `cardio:ctgov-nct04007315-2020-05-15`, retrieved 2026-10-26)
- Started: 2019-11-21 (actual) (ClinicalTrials.gov record NCT04007315, source copy `cardio:ctgov-nct04007315-2020-05-15`, retrieved 2026-10-26)
- Primary completion: 2022-07 (anticipated) (ClinicalTrials.gov record NCT04007315, source copy `cardio:ctgov-nct04007315-2020-05-15`, retrieved 2026-10-26)
- Completion: 2022-07 (anticipated) (ClinicalTrials.gov record NCT04007315, source copy `cardio:ctgov-nct04007315-2020-05-15`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT04007315, source copy `cardio:ctgov-nct04007315-2020-05-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04007315-2020-05-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: SaeboGlove Therapy for Severe Upper Limb Disability and Severe Hand Impairment After Stroke
- Acronym: SUSHI
- Condition: Stroke
- Intervention (Device): SaeboGlove therapy
- Intervention (Behavioral): Usual care
- Lead sponsor: NHS Greater Glasgow and Clyde
- Lead sponsor class: OTHER
- Collaborator: University of Glasgow
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: NHS Greater Glasgow and Clyde (`cardio:org-nhs-greater-glasgow-and-clyde`)
- Registry lists this organization as a collaborator: University of Glasgow (`cardio:org-university-of-glasgow`)

## Provenance

Content hash: d56678497a172460930706bd0bb25252f4a0c3ccfe5229c75087ebcaef7dc8cb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
